Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132183) titled 'Effect of COM-B Model-Based Home Medication Management on Capecitabine Adherence in Patients with Metastatic Colorectal Cancer Receiving First-Line CAPOX Plus Bevacizumabs' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tongde Hospital of Zhejiang Province
Condition:
mCRC
Intervention:
Control group:Conventional drug therapy and standard education
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-09-10
Target Sample Size: Control group:75;Intervention group:75;
Countries of Recruitment:
China
To know more, visit https://www.c...